SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Lotta L. A.)
 

Search: WFRF:(Lotta L. A.) > (2015-2019) > Elevated Plasma Lev...

  • Mardinoglu, Adil,1982KTH,Science for Life Laboratory, SciLifeLab (author)

Elevated Plasma Levels of 3-Hydroxyisobutyric Acid Are Associated With Incident Type 2 Diabetes

  • Article/chapterEnglish2018

Publisher, publication year, extent ...

  • Elsevier BV,2018

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/265450
  • https://gup.ub.gu.se/publication/265450URI
  • https://doi.org/10.1016/j.ebiom.2017.12.008DOI
  • https://research.chalmers.se/publication/505754URI
  • https://research.chalmers.se/publication/501356URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-224059URI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • QC 20180316
  • Branched-chain amino acids (BCAAs) metabolite, 3-Hydroxyisobutyric acid (3-HIB) has been identified as a secreted mediator of endothelial cell fatty acid transport and insulin resistance (IR) using animal models. To identify if 3-HIB is a marker of human IR and future risk of developing Type 2 diabetes (T2D), we measured plasma levels of 3-HIB and associated metabolites in around 10,000 extensively phenotyped individuals. The levels of 3-HIB were increased in obesity but not robustly associated with degree of IR after adjusting for BMI. Nevertheless, also after adjusting for obesity and plasma BCAA, 3-HIB levels were associated with future risk of incident T2D. We also examined the effect of 3-HIB on fatty acid uptake in human cells and found that both HUVEC and human cardiac endothelial cells respond to 3-HIB whereas human adipose tissue-derived endothelial cells do not respond to 3-HIB. In conclusion, we found that increased plasma level of 3-HIB is a marker of future risk of T2D and 3-HIB may be important for the regulation of metabolic flexibility in heart and muscles.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Gogg, Silvia,1962Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,University of Gothenburg(Swepub:gu)xgogsi (author)
  • Lotta, L. A.University Of Cambridge (author)
  • Stancakova, A. (author)
  • Nerstedt, Annika,1960Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,University of Gothenburg(Swepub:gu)xneran (author)
  • Borén, Jan,1963Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,University of Gothenburg(Swepub:gu)xborej (author)
  • Bluher, M.Universität Leipzig,Leipzig University (author)
  • Ferrannini, E. (author)
  • Langenberg, C.University Of Cambridge (author)
  • Wareham, N. J.University Of Cambridge (author)
  • Laakso, M.Itä-Suomen Yliopisto,University of Eastern Finland (author)
  • Smith, Ulf,1943Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,University of Gothenburg(Swepub:gu)xsmiul (author)
  • KTHScience for Life Laboratory, SciLifeLab (creator_code:org_t)

Related titles

  • In:Ebiomedicine: Elsevier BV27, s. 151-1552352-3964

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view